Sana Biotechnology Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.5% | +20.5% | -9.2% | -9.6% | -10.4% | -11.1% | -18.8% | +20.4% | -4.3% | -10.4% | +15.5% | |
| – | -23.6% | +50.5% | -18.0% | -20.2% | -23.5% | -29.9% | -26.8% | +96.1% | -8.1% | -24.9% | +52.8% | |
| – | -20.7% | +32.6% | -23.8% | -5.9% | +0.4% | -24.6% | -25.9% | +45.0% | -30.5% | +16.6% | -31.9% | |
| – | -23.6% | +51.6% | -19.1% | -20.9% | -23.4% | -31.3% | -30.6% | +110.6% | -9.6% | -26.9% | +58.7% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +4.6% | +10.2% | -8.9% | -4.3% | -6.1% | -5.6% | +1.1% | +0.4% | +6.6% | -0.6% | +8.9% | |
| – | -3.2% | -18.0% | -4.2% | -7.3% | -3.3% | -27.0% | +0.9% | +6.2% | +121.7% | +9.6% | +43.5% | |
| – | -2.2% | -0.2% | -24.1% | +6.0% | +18.2% | +3.7% | +6.4% | +6.8% | +1.2% | -0.4% | -2.5% | |
| – | -58.6% | +48.4% | -37.4% | -21.6% | +74.2% | -81.0% | +129.5% | -18.1% | -10.2% | +27.2% | -36.0% | |
| – | -21.4% | +30.5% | -9.5% | -13.9% | -14.4% | -16.5% | -41.4% | +59.4% | -17.6% | -25.9% | +29.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.6% | +10.1% | +7.9% | +0.4% | +0.4% | +0.5% | +0.3% | +9.3% | -2.8% | +9.3% | +6.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.